Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2BGN

HIV-1 Tat protein derived N-terminal nonapeptide Trp2-Tat(1-9) bound to the active site of Dipeptidyl peptidase IV (CD26)

2BGN の概要
エントリーDOI10.2210/pdb2bgn/pdb
関連するPDBエントリー1J2E 1KRM 1N1M 1NDV 1NDW 1NDY 1NDZ 1NU6 1NU8 1O5R 1PFQ 1QXL 1R9M 1RWQ 1TK3 1TKR 1U8E 1UML 1V78 1V79 1V7A 1W1I 2BGR
分子名称DIPEPTIDYL PEPTIDASE IV, ADENOSINE DEAMINASE, TAT PROTEIN, ... (9 entities in total)
機能のキーワードhydrolase, hydrolase-complex, dipetidyl peptidase iv, dppiv, cd26, alpha/beta-hydrolase fold, beta-propeller fold, protein-protein complex, adenosine deaminase, ada, serine protease, aminopeptidase, hiv-1 tat protein
由来する生物種HOMO SAPIENS (HUMAN)
詳細
タンパク質・核酸の鎖数12
化学式量合計519082.89
構造登録者
Weihofen, W.A.,Liu, J.,Reutter, W.,Saenger, W.,Fan, H. (登録日: 2005-01-03, 公開日: 2005-01-27, 最終更新日: 2025-10-01)
主引用文献Weihofen, W.A.,Liu, J.,Reutter, W.,Saenger, W.,Fan, H.
Crystal Structures of HIV-1 Tat-Derived Nonapeptides Tat-(1-9) and Trp2-Tat-(1-9) Bound to the Active Site of Dipeptidyl-Peptidase Iv (Cd26)
J.Biol.Chem., 280:14911-, 2005
Cited by
PubMed Abstract: CD26 or dipeptidyl-peptidase IV (DPPIV) is engaged in immune functions by co-stimulatory effects on activation and proliferation of T lymphocytes, binding to adenosine deaminase, and regulation of various chemokines and cytokines. DPPIV peptidase activity is inhibited by both Tat protein from human immunodeficiency virus (HIV)-1 and its N-terminal nonapeptide Tat-(1-9) with amino acid sequence MDPVDPNIE, suggesting that DPPIV mediates immunosuppressive effects of Tat protein. The 2.0- and 3.15-A resolution crystal structures of the binary complex between human DPPIV and nonapeptide Tat-(1-9) and the ternary complex between the variant MWPVDPNIE, called Trp(2)-Tat-(1-9), and DPPIV bound to adenosine deaminase show that Tat-(1-9) and Trp(2)-Tat-(1-9) are located in the active site of DPPIV. The interaction pattern of DPPIV with Trp(2)-Tat-(1-9) is tighter than that with Tat-(1-9), in agreement with inhibition constants (K(i)) of 2 x 10(-6) and 250 x 10(-6) m, respectively. Both peptides cannot be cleaved by DPPIV because the binding pockets of the N-terminal 2 residues are interchanged compared with natural substrates: the N-terminal methionine occupies the hydrophobic S1 pocket of DPPIV that normally accounts for substrate specificity by binding the penultimate residue. Because the N-terminal sequence of the thromboxane A2 receptor resembles the Trp(2)-Tat-(1-9) peptide, a possible interaction with DPPIV is postulated.
PubMed: 15695814
DOI: 10.1074/JBC.M413400200
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (3.15 Å)
構造検証レポート
Validation report summary of 2bgn
検証レポート(詳細版)ダウンロードをダウンロード

251801

件を2026-04-08に公開中

PDB statisticsPDBj update infoContact PDBjnumon